| Literature DB >> 33827444 |
Jung-Yeon Choi1, Jin-Kak Kim2, Kwang-Il Kim3,4, Young-Kyun Lee2, Kyung-Hoi Koo2,5, Cheol-Ho Kim1,6.
Abstract
BACKGROUND: Frailty and low handgrip strength (HGS) are associated with adverse outcomes after hip fracture (HF) surgery. We aimed to compare the predictive role of frailty and HGS for adverse outcome in HF patients.Entities:
Keywords: Frailty; Grip strength; Hip fracture; Multidimensional frailty score; Postoperative complication
Year: 2021 PMID: 33827444 PMCID: PMC8028224 DOI: 10.1186/s12877-021-02150-9
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Comparison of demographic, laboratory, and CGA domains by postoperative complication
| No Complication | Complication | ||
|---|---|---|---|
| Age (year) | 80.3 (6.4) | 83.1 (6.8) | |
| Sex (male/female) | 35/101 | 30/76 | 0.655 |
| Body mass index (kg/m2) | 22.0 (3.7) | 20.9 (3.8) | |
| ASA class (1/2/3/4) a | 6/77/29/3 | 6/43/43/1 | |
| Type of fracture (neck/intertrochanter) | 66/70 | 55/51 | 0.604 |
| Anesthesia (general/spinal) | 109/27 | 94/12 | 0.073 |
| WBCs (× 103/μL) | 9.8 (3.6) | 9.7 (3.5) | 0.828 |
| Hemoglobin (g/dL) | 11.5 (2.0) | 11.1 (2.0) | 0.093 |
| Platelets (× 103/μL) | 216.1 (81.0) | 198.2 (73.0) | 0.076 |
| BUN (mg/dL) | 20.0 (11.9) | 22.3 (14.3) | 0.165 |
| Creatinine (mg/dL) | 0.99 (0.92) | 1.22 (1.44) | 0.137 |
| Total Cholesterol (mg/dL) | 162.0 (37.8) | 150.4 (35.5) | |
| Protein (mg/dL) | 6.7 (0.6) | 6.5 (0.7) | |
| Albumin (mg/dL) | 3.8 (0.4) | 3.5 (0.5) | |
| Charlson’s comorbidity index | 1.5 (1.7) | 1.9 (1.8) | 0.118 |
| Polypharmacy (≥5) | 96 (70.6%) | 78 (73.6%) | 0.607 |
| ADL dependency (partial and full) b | 58 (42.6%) | 69 (65.7%) | |
| IADL dependency b | 70 (51.5%) | 80 (76.2%) | |
| MMSE-KC | 20.4 (6.4) | 14.8 (7.1) | |
| SGDS-Kc | 4.9 (3.7) | 6.4 (4.6) | |
| Risk of falling (≥10) | 42 (30.9%) | 55 (51.9%) | |
| MNA | 22.0 (4.2) | 19.6 (4.7) | |
| Mid-arm circumference (cm) | 24.4 (11.4) | 22.6 (3.1) | 0.112 |
| Grip strength (kg) | 17.7 (7.4) | 13.4 (5.9) | |
| The Koval grade | 2.2 (1.7) | 2.6 (1.8) | 0.074 |
| Hip-MFS | 6.1 (2.8) | 7.8 (2.3) | |
Data are presented as mean (SD) or number (%)
ADL activities of daily living, ALT alanine aminotransferase, AST aspartate aminotransferase, ASA American Society of Anesthesiologists, CGA comprehensive geriatric assessment, IADL instrumental activities of daily living, MMSE-KC Korean version of the mini-mental status examination, SGDS-K short form of the Korean Geriatric Depression Scale, MNA Mini Nutritional Assessment, Nu-DESC Nursing Delirium Screening Scale, WBC white blood cell
aData were missing for 34 patients
bData were missing for 1 patient
cData were missing for 64 patients
Adjusted odds ratios and hazard ratios by grip strength, gait speed, and other risk factors for postoperative complications, 6-month mortality, and mortality at the end of follow-up
| Model 1 | Model 2 | Model 3 | |
|---|---|---|---|
| Complication | |||
| Grip strength (per kg) | 1.147 (1.085–1.213)† | 1.151 (1.088–1.218)† | 1.147 (1.082–1.215)† |
| Hip-MFS | 1.260 (1.118–1.422)† | 1.275 (1.127–1.442)† | 1.250 (1.092–1.432)* |
| ASA classificationd | 1.566 (0.971–2.526) | 1.563 (0.969–2.521) | 1.347 (0.804–2.257) |
| 6-month mortality | |||
| Grip strength (per kg) | 1.116 (1.023–1.217)* | 1.111 (1.015–1.216)* | 1.101 (0.985–1.231) |
| Hip-MFS | 1.603 (1.235–2.080)‡ | 1.530 (1.183–1.979)† | 1.403 (1.027–1.917)* |
| ASA classificationd | 2.236 (1.076–4.645)* | 2.449 (1.134–5.290)* | 3.066 (1.106–8.503)* |
| Mortality at the end of follow-up | |||
| Grip strength (per kg) | 1.094 (1.040–1.152)∥ | 1.093 (1.037–1.151)† | 1.080 (1.024–1.139)* |
| Hip-MFS | 1.546 (1.334–1.795)‡ | 1.538 (1.323–1.788)‡ | 1.493 (1.259–1.769)* |
| ASA classification d | 1.725 (1.094–2.718)* | 1.750 (1.106–2.770)* | 1.551 (0.908–2.651) |
Data are presented as hazard ratio (95% confidence interval)
aAdjusted by age, sex, and body mass index
bAdjusted by age, sex, body mass index, and type of fracture
cAdjusted by age, sex, body mass index, type of fracture, white blood cell count, hemoglobin, total cholesterol, protein, blood urea nitrogen, and creatinine
dData were missing for 34 patients
*p < 0.05, †p < 0.01, ‡p < 0.001
Fig. 1Additional prognostic utility of the Hip-MFS and grip strength with the ASA classification in predicting postoperative complications. a ASA vs. ASA + Hip-MFS. b ASA vs. ASA + grip strength. Hip-MFS: hip-multidimensional frailty score, ASA: American Society of Anesthesiologists
Fig. 2Time-dependent receiver-operating characteristic (ROC) curves at 1000 days based on the Hip-MFS- (red) and grip strength- (blue) based prognostic model for mortality at the end of follow-up. a Model 1: Adjusted by age, sex, and body mass index. b Model 2: Adjusted by age, sex, body mass index, and type of fracture. c Model 3: Adjusted by age, sex, body mass index, type of fracture, white blood cell count, hemoglobin, total cholesterol, protein, blood urea nitrogen, and creatinine. Hip-MFS: hip-multidimensional frailty score
Fig. 3Cumulative 6-month mortality rate according to risk stratification based on the Hip-MFS and grip strength. Comparison of the Kaplan–Meier survival curves between (a) high-risk vs. low-risk Hip-MFS groups and (b) low vs. high grip strength groups. Log-rank test showing a significant difference between the Hip-MFS groups but not between the grip strength groups. Hip-MFS: hip-multidimensional frailty score